Literature DB >> 16790809

The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages.

Wilson J Ribot1, Ricky L Ulrich.   

Abstract

Burkholderia mallei is a highly infectious gram-negative pathogen and is the causative agent of human and animal glanders. By generating polar mutations (disruption of bsaQ and bsaZ) in the B. mallei ATCC 23344 animal pathogen-like type III secretion system (TTS), we demonstrate that this bacterial protein delivery system is required for intracellular growth of B. mallei in J774.2 cells, formation of macrophage membrane protrusions, actin polymerization, and phagosomal escape. These findings suggest that TTS plays a role in the intracellular trafficking of B. mallei and may facilitate cell-to-cell spread via actin-based motility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790809      PMCID: PMC1489733          DOI: 10.1128/IAI.01939-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.

Authors:  Ricky L Ulrich; David DeShazer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity.

Authors:  Mark P Stevens; Andrea Friebel; Lowrie A Taylor; Michael W Wood; Philip J Brown; Wolf-Dietrich Hardt; Edouard E Galyov
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

3.  Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB.

Authors:  Supaporn Suparak; Wannapa Kespichayawattana; Ashraful Haque; Anna Easton; Suwat Damnin; Ganjana Lertmemongkolchai; Gregory J Bancroft; Sunee Korbsrisate
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 4.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

Review 5.  Salmonella interactions with host cells: type III secretion at work.

Authors:  J E Galán
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

6.  Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.

Authors:  D DeShazer; D M Waag; D L Fritz; D E Woods
Journal:  Microb Pathog       Date:  2001-05       Impact factor: 3.738

7.  Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes.

Authors:  Bryan H Bellaire; R Martin Roop; James A Cardelli
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.

Authors:  Ricky L Ulrich; Kei Amemiya; David M Waag; Chad J Roy; David DeShazer
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641

9.  Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.

Authors:  Jonathan Warawa; Donald E Woods
Journal:  FEMS Microbiol Lett       Date:  2005-01-01       Impact factor: 2.742

10.  Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant.

Authors:  Joanne M Stevens; Ricky L Ulrich; Lowrie A Taylor; Michael W Wood; David Deshazer; Mark P Stevens; Edouard E Galyov
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

View more
  16 in total

1.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

2.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

4.  The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model.

Authors:  Paula J Fernandes; Qin Guo; David M Waag; Michael S Donnenberg
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

5.  Stable, site-specific fluorescent tagging constructs optimized for burkholderia species.

Authors:  Michael H Norris; Yun Kang; Bruce Wilcox; Tung T Hoang
Journal:  Appl Environ Microbiol       Date:  2010-09-17       Impact factor: 4.792

6.  Burkholderia mallei cellular interactions in a respiratory cell model.

Authors:  Gregory C Whitlock; Gustavo A Valbuena; Vsevolod L Popov; Barbara M Judy; D Mark Estes; Alfredo G Torres
Journal:  J Med Microbiol       Date:  2009-05       Impact factor: 2.472

7.  Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.

Authors:  Andrea Haraga; T Eoin West; Mitchell J Brittnacher; Shawn J Skerrett; Samuel I Miller
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

8.  Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.

Authors:  John Shanks; Mary N Burtnick; Paul J Brett; David M Waag; Kevin B Spurgers; Wilson J Ribot; Mark A Schell; Rekha G Panchal; Frank C Gherardini; Keith D Wilkinson; David Deshazer
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

9.  Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.

Authors:  Rachel Balder; Serena Lipski; John J Lazarus; William Grose; Ronald M Wooten; Robert J Hogan; Donald E Woods; Eric R Lafontaine
Journal:  BMC Microbiol       Date:  2010-09-28       Impact factor: 3.605

10.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.